U.S. states allege broad generic drug price-fixing collusion

This post was originally published on this site

WASHINGTON (Reuters) – A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling.